40 results
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
13 Nov 23
Other Events
12:32pm
, and shall be reimbursed all of its related costs and expenses
9. Certain Intellectual Property Rights Matters:
9.1. Responsibility Outside of Territory … , and copyright filings received or made by GTC outside of the Territory pertaining to GTC-IP.
9.2. Responsibility in Territory. IndiaCo shall recommend to GTC
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
22 Jun 23
Globestar Therapeutics Enters into Mou with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
5:18pm
will lead the effort, contribute related rights to Project Amethyst™, and have primary responsibility for financing, supply chain, manufacturing, and sales … of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
12 Oct 21
Regulation FD Disclosure
8:27am
” or similar expressions. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information
8-K
EX-99
hl1xrm
4 Oct 21
Regulation FD Disclosure
8:48am
8-K
EX-99
pi8m4qf37
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
4kyuj8a6vly
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
2v7eu2h74qa
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
u3rjj4lsbk4y zw
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
s5t5 wvg704
16 Apr 21
AngioSoma, Inc. Is Pleased to Welcome William Farley to Its Board of Directors
4:20pm
8-K
EX-99
p8tvfhbfv
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
8-K
EX-99
wbnfbded2eldgk225t
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
8-K
EX-99
l71tzxcvamgxjve q9
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm
8-K
EX-99.1
2ztxe nlrh9bukhkh
23 Oct 19
AngioSoma, Inc. Announces Settlement of Litigation
11:28am
8-K
EX-99
eszpaj38
19 Aug 19
Regulation FD Disclosure
9:41pm